1. |
HASSAN K, ROGUIN N, KAGANOV Y, et al. Effect of erythropoietin therapy on red cells filterability and left ventricularmass in p redialysis patients[J]. Ren Fail, 2005, 27 (2): 177 182.
|
2. |
季大玺. 维持性血液透析远期并发症的防治[J]. 医学研究生学报,2008,21(6):561-563.
|
3. |
SLININ Y, FOLEY R N, COLLINSAJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study[J]. J Am Soc N ephrol, 2005, 16 (6): 1788-1793.
|
4. |
GOICOECHEAM, D E VINUESA S G, GóMEZCAMPDER àF, et al. Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD) [J]. Kidney Int Suppl, 2005, (93): S35-S38.
|
5. |
BLOCK G A, KLASSEN P S, LAZARUS J M, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis[J]. J A m Soc Nephrol, 2004,15: 2208-2218.
|
6. |
LINDSAY R M, ALHEJAILI F, NESRALLAH G, et al. Calcium and phosphate balance with quotidian hemodialysis[J]. Am J Kidney Dis, 2003, 42 (1 Suppl): 24-29.
|
7. |
陈江华,何强,谢文卿,等. 高危尿毒症患者每日短时透析的临床初步经验[J]. 中华肾脏病杂志,2005,21(5):286-289.
|